Market research
BSGM Biosig Technologies Inc
OTCQB USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 215M
- P/E ratio
- Not available
- Analyst target
- 10
- Dividend yield
- Not available
- Beta
- 1.82
Profile
Company facts
- Exchange
- OTCQB
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US09073N2018
- Market cap
- 215M
- P/E ratio
- Not available
- Analyst target
- 10
- Dividend yield
- Not available
- Beta
- 1.82
About
About Biosig Technologies Inc
BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale. The company also designs and develops an online platform for real-world asset (RWA) tokenization. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Los Angeles, California.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the BSGM discussion.
5 years, 4 months ago
BioSig Technologies, Inc is currently in a long term downtrend where the price is trading 9.9% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
BioSig Technologies, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 30.4% to $-10M since the same quarter in the previous year.
Finally, its free cash flow fell by 53.5% to $-6M since the same quarter in the previous year.
Based on the above factors, BioSig Technologies, Inc gets an overall score of 2/5.